{
    "protocolSection": {
        "identificationModule": {
            "nctId": "NCT06008795",
            "orgStudyIdInfo": {
                "id": "IRB CED000000829"
            },
            "secondaryIdInfos": [
                {
                    "id": "1U01NS124613-01A1",
                    "type": "NIH",
                    "link": "https://reporter.nih.gov/quickSearch/1U01NS124613-01A1"
                }
            ],
            "organization": {
                "fullName": "University of Florida",
                "class": "OTHER"
            },
            "briefTitle": "BLOCK-SAH - PPF-Block for Post-SAH Headache",
            "officialTitle": "Pterygopalatine Fossa (PPF) Block as an Opioid Sparing Treatment for Acute Headache in Aneurysmal Subarachnoid Hemorrhage",
            "acronym": "BLOCK-SAH",
            "therapeuticArea": [
                "Other"
            ],
            "study": "block-sah-ppf-block-for-post-sah-headache"
        },
        "statusModule": {
            "statusVerifiedDate": "2024-01",
            "overallStatus": "RECRUITING",
            "expandedAccessInfo": {
                "hasExpandedAccess": false
            },
            "startDateStruct": {
                "date": "2023-12-17",
                "type": "ACTUAL"
            },
            "primaryCompletionDateStruct": {
                "date": "2027-01-15",
                "type": "ESTIMATED"
            },
            "completionDateStruct": {
                "date": "2027-02-28",
                "type": "ESTIMATED"
            },
            "studyFirstSubmitDate": "2023-08-18",
            "studyFirstSubmitQcDate": "2023-08-18",
            "studyFirstPostDateStruct": {
                "date": "2023-08-24",
                "type": "ACTUAL"
            },
            "lastUpdateSubmitDate": "2024-02-28",
            "lastUpdatePostDateStruct": {
                "date": "2024-03-01",
                "type": "ACTUAL"
            }
        },
        "sponsorCollaboratorsModule": {
            "responsibleParty": {
                "type": "SPONSOR"
            },
            "leadSponsor": {
                "name": "University of Florida",
                "class": "OTHER"
            },
            "collaborators": [
                {
                    "name": "National Institute of Neurological Disorders and Stroke (NINDS)",
                    "class": "NIH"
                },
                {
                    "name": "New York University",
                    "class": "OTHER"
                },
                {
                    "name": "Massachusetts General Hospital",
                    "class": "OTHER"
                }
            ]
        },
        "oversightModule": {
            "oversightHasDmc": true,
            "isFdaRegulatedDrug": true,
            "isFdaRegulatedDevice": false
        },
        "descriptionModule": {
            "briefSummary": "BLOCK-SAH is a phase II, multicenter, randomized, double-blinded, placebo-controlled clinical trial with a sequential parallel comparison design (SPCD) of bilateral pterygopalatine fossa (PPF) injections with 20mg ropivacaine + 4mg dexamethasone (active, PPF-block) compared to saline (placebo) for headache in survivors of aneurysmal subarachnoid hemorrhage (SAH), while monitoring intracranial arterial mean flow velocities with transcranial Doppler (TCD) peri-intervention (intervention = PPF-injections: active or placebo)"
        },
        "conditionsModule": {
            "conditions": [
                "Subarachnoid Hemorrhage, Aneurysmal",
                "Headache"
            ],
            "keywords": [
                "Pterygopalatine Fossa Nerve Block"
            ]
        },
        "designModule": {
            "studyType": "INTERVENTIONAL",
            "phases": [
                "PHASE2"
            ],
            "designInfo": {
                "allocation": "RANDOMIZED",
                "interventionModel": "SEQUENTIAL",
                "interventionModelDescription": "Sequential Parallel Comparison Design",
                "primaryPurpose": "TREATMENT",
                "maskingInfo": {
                    "masking": "QUADRUPLE",
                    "whoMasked": [
                        "PARTICIPANT",
                        "CARE_PROVIDER",
                        "INVESTIGATOR",
                        "OUTCOMES_ASSESSOR"
                    ]
                }
            },
            "enrollmentInfo": {
                "count": 195,
                "type": "ESTIMATED"
            }
        },
        "armsInterventionsModule": {
            "armGroups": [
                {
                    "label": "Group 1 - Active - Active",
                    "type": "ACTIVE_COMPARATOR",
                    "description": "Subjects randomized to Group 1 will receive an active PPF nerve block in Stage 1 followed by an active PPF nerve block in Stage 2 of the Double-Blinded Trial Phase",
                    "interventionNames": [
                        "Drug: Pterygopalatine Fossa Nerve Block with Ropivacaine and Dexamethasone"
                    ]
                },
                {
                    "label": "Group 2 - Placebo - Active",
                    "type": "OTHER",
                    "description": "Subjects randomized to Group 2 will receive a placebo PPF-injection in Stage 1 followed by an active PPF nerve block in Stage 2 of the Double-Blinded Trial Phase",
                    "interventionNames": [
                        "Drug: Pterygopalatine Fossa Nerve Block with Ropivacaine and Dexamethasone",
                        "Procedure: Placebo Pteryogpalatine Fossa Injection"
                    ]
                },
                {
                    "label": "Group 3 - Placebo - Placebo",
                    "type": "PLACEBO_COMPARATOR",
                    "description": "Subjects randomized to Group 3 will receive a placebo PPF-injection in Stage 1 followed by a placebo PPF-injection in Stage 2 of the Double-Blinded Trial Phase",
                    "interventionNames": [
                        "Procedure: Placebo Pteryogpalatine Fossa Injection"
                    ]
                }
            ],
            "interventions": [
                {
                    "type": "DRUG",
                    "name": "Pterygopalatine Fossa Nerve Block with Ropivacaine and Dexamethasone",
                    "description": "Each PPF-active nerve block will consist of 20mg (4ml) ropivacaine plus 4mg (1ml) dexamethasone",
                    "armGroupLabels": [
                        "Group 1 - Active - Active",
                        "Group 2 - Placebo - Active"
                    ],
                    "otherNames": [
                        "Pterygopalatine Fossa Nerve Block"
                    ]
                },
                {
                    "type": "PROCEDURE",
                    "name": "Placebo Pteryogpalatine Fossa Injection",
                    "description": "Each placebo PPF-injection will consist of 5ml normal saline",
                    "armGroupLabels": [
                        "Group 2 - Placebo - Active",
                        "Group 3 - Placebo - Placebo"
                    ]
                }
            ]
        },
        "outcomesModule": {
            "primaryOutcomes": [
                {
                    "measure": "Primary Efficacy Endpoint",
                    "description": "prn oral morphine equivalent (OME)/day use",
                    "timeFrame": "within 24 hours after each PPF-injection spanning the 48 hours of double-blinded treatment period"
                },
                {
                    "measure": "Primary Safety Endpoint",
                    "description": "incidence of radiographic vasospasm",
                    "timeFrame": "at 48 hours from first PPF-injection (end of double-blinded treatment period)"
                },
                {
                    "measure": "Primary Tolerability Endpoint",
                    "description": "rate of acceptance of second PPF-injection",
                    "timeFrame": "at 24 hours following the first PPF-injection"
                }
            ]
        },
        "eligibilityModule": {
            "eligibilityCriteria": "Inclusion Criteria:\n\nIn order to be eligible to participate in this study, an individual must meet all of the following criteria:\n\n1. Provision of signed and dated informed consent form\n2. Stated willingness to comply with all study procedures and availability for the duration of the study\n3. Male or female, aged \u226518 and \u2264 85 years\n4. Admitted with a primary diagnosis of spontaneous, non-traumatic, subarachnoid hemorrhage within 48 hours of ictus hemorrhage\n5. Disease-specific inclusion criteria:\n\n   1. Aneurysm identified as culprit of SAH\n   2. Modified Fisher grade 1-4 (on admission imaging)\n   3. Hunt and Hess 1-3 or World Federation of Neurosurgeons grade 1-4 (on admission, included only if also fulfilling Glasgow Coma Scale verbal subscore\u22654)\n   4. Minimum Glasgow Coma Scale verbal subscore of 4 (on screening)\n6. Able to verbalize pain scale scores according to 11-point numeric pain scale\n\n   In order to be enrolled and undergo randomization in this study, an individual must meet all of the additional criteria:\n7. Stabilization period criteria:\n\n   1. A minimum of 4 hours from clipping or coiling procedure (whichever applicable)\n   2. Successful treatment of culprit vascular lesion (i.e., \u226590% obliteration of aneurysm)\n8. Requiring a minimum of 15mg OME prn for headache analgesia during any 24-hour period during eligibility period\n\nExclusion Criteria:\n\nAn individual who meets any of the following criteria will be excluded from participation in this study:\n\n1. Premorbid conditions:\n\n   * Pre-existing neurologic, psychiatric, or other condition that would confound neurologic assessment or would make difficult/impossible to accurately assess neurologic and/or functional outcome\n   * Pre-existing diffuse flow-limiting narrowing of arteries in the Circle of Willis, regardless of etiology (e.g., atherosclerosis, vasculitis, Moya-Moya syndrome)\n   * Prior use of opioid or barbiturate analgesics for at least two-thirds of the days in previous month, regardless of indication\n   * Diagnosis of substance use disorder in the previous year\n   * Infected or wounded skin, or a skin lesion at the site of puncture for PPF-injection\n2. Uncorrected coagulopathy\n\n   * Platelet count \\< 50,000/\u03bcL, International Normalized Ratio (INR) \\> 1.7\n   * Requiring use of systemic anticoagulation and antiplatelet therapy (except for aspirin monotherapy).\n3. SAH-specific:\n\n   * Head trauma as etiology of SAH\n   * Infection as cause for aneurysm or SAH (i.e., mycotic aneurysms)\n   * Inability to successfully treat culprit vascular lesion\n   * Diffuse vasospasm on initial diagnostic CTA or digital subtraction angiography (DSA). Vasospasm is defined as moderate-to-severe arterial narrowing on DSA or CTA not attributable to atherosclerosis, catheter-induced spasm, or vessel hypoplasia, as determined by a neuroradiologist or neurointerventionalist\n4. Standard pain regimen conditions\n\n   * Elevation of hepatic enzymes prohibiting use of scheduled acetaminophen (i.e., AST or ALT \\> 3x upper limit level)\n   * Chronic liver condition with absolute contra-indication for acetaminophen (even at lower maximum daily doses)\n5. Participation in a concurrent investigational/interventional study (observational studies allowed)\n6. Known to be pregnant, or with a positive pregnancy test\n7. Allergy or intolerance to the medications used in the PPF-block (i.e., ropivacaine, dexamethasone) or standard pain regimen (acetaminophen)\n8. Vulnerable populations such as, prisoners and inmates (abiding GCP per the study IRB)\n9. Unable to receive first PPF-injection within 96 hours of ictus hemorrhage",
            "healthyVolunteers": false,
            "sex": "ALL",
            "minimumAge": "18 Years",
            "maximumAge": "85 Years",
            "stdAges": [
                "ADULT",
                "OLDER_ADULT"
            ]
        },
        "contactsLocationsModule": {
            "centralContacts": [
                {
                    "name": "Yurerkis Montas",
                    "role": "CONTACT",
                    "phone": "617-866-9758",
                    "email": "ymontas@partners.org"
                },
                {
                    "name": "Ralisa Pop",
                    "role": "CONTACT",
                    "phone": "352-294-5693",
                    "email": "ralisa.pop@neurology.ufl.edu"
                }
            ],
            "locations": [
                {
                    "facility": "University of Florida",
                    "status": "RECRUITING",
                    "city": "Gainesville",
                    "state": "Florida",
                    "zip": "32610",
                    "country": "United States",
                    "contacts": [
                        {
                            "name": "Carolina Maciel, MD MSCR",
                            "role": "CONTACT",
                            "phone": "352-273-5500",
                            "email": "carolina.maciel@neurology.ufl.edu"
                        }
                    ],
                    "geoPoint": {
                        "lat": 29.65163,
                        "lon": -82.32483
                    }
                },
                {
                    "facility": "Mayo Clinic",
                    "status": "RECRUITING",
                    "city": "Rochester",
                    "state": "Minnesota",
                    "zip": "55009",
                    "country": "United States",
                    "contacts": [
                        {
                            "name": "Amy Headlee",
                            "role": "CONTACT"
                        },
                        {
                            "name": "Narayan Kissoon",
                            "role": "PRINCIPAL_INVESTIGATOR"
                        }
                    ],
                    "geoPoint": {
                        "lat": 44.02163,
                        "lon": -92.4699
                    }
                }
            ]
        }
    },
    "derivedSection": {
        "miscInfoModule": {
            "versionHolder": "2024-07-30"
        },
        "conditionBrowseModule": {
            "meshes": [
                {
                    "id": "D000013345",
                    "term": "Subarachnoid Hemorrhage"
                },
                {
                    "id": "D000006470",
                    "term": "Hemorrhage"
                },
                {
                    "id": "D000006261",
                    "term": "Headache"
                }
            ],
            "ancestors": [
                {
                    "id": "D000010335",
                    "term": "Pathologic Processes"
                },
                {
                    "id": "D000010146",
                    "term": "Pain"
                },
                {
                    "id": "D000009461",
                    "term": "Neurologic Manifestations"
                },
                {
                    "id": "D000020300",
                    "term": "Intracranial Hemorrhages"
                },
                {
                    "id": "D000002561",
                    "term": "Cerebrovascular Disorders"
                },
                {
                    "id": "D000001927",
                    "term": "Brain Diseases"
                },
                {
                    "id": "D000002493",
                    "term": "Central Nervous System Diseases"
                },
                {
                    "id": "D000009422",
                    "term": "Nervous System Diseases"
                },
                {
                    "id": "D000014652",
                    "term": "Vascular Diseases"
                },
                {
                    "id": "D000002318",
                    "term": "Cardiovascular Diseases"
                }
            ],
            "browseLeaves": [
                {
                    "id": "M9556",
                    "name": "Hemorrhage",
                    "asFound": "Hemorrhage",
                    "relevance": "HIGH"
                },
                {
                    "id": "M16135",
                    "name": "Subarachnoid Hemorrhage",
                    "asFound": "Subarachnoid Hemorrhage",
                    "relevance": "HIGH"
                },
                {
                    "id": "M9351",
                    "name": "Headache",
                    "asFound": "Headache",
                    "relevance": "HIGH"
                },
                {
                    "id": "M13066",
                    "name": "Pain",
                    "relevance": "LOW"
                },
                {
                    "id": "M12404",
                    "name": "Neurologic Manifestations",
                    "relevance": "LOW"
                },
                {
                    "id": "M22113",
                    "name": "Intracranial Hemorrhages",
                    "relevance": "LOW"
                },
                {
                    "id": "M5810",
                    "name": "Cerebrovascular Disorders",
                    "relevance": "LOW"
                },
                {
                    "id": "M5204",
                    "name": "Brain Diseases",
                    "relevance": "LOW"
                },
                {
                    "id": "M5742",
                    "name": "Central Nervous System Diseases",
                    "relevance": "LOW"
                },
                {
                    "id": "M17400",
                    "name": "Vascular Diseases",
                    "relevance": "LOW"
                },
                {
                    "id": "T170",
                    "name": "Acute Graft Versus Host Disease",
                    "relevance": "LOW"
                }
            ],
            "browseBranches": [
                {
                    "abbrev": "BC23",
                    "name": "Symptoms and General Pathology"
                },
                {
                    "abbrev": "All",
                    "name": "All Conditions"
                },
                {
                    "abbrev": "BC10",
                    "name": "Nervous System Diseases"
                },
                {
                    "abbrev": "BC14",
                    "name": "Heart and Blood Diseases"
                },
                {
                    "abbrev": "Rare",
                    "name": "Rare Diseases"
                }
            ]
        },
        "interventionBrowseModule": {
            "meshes": [
                {
                    "id": "D000003907",
                    "term": "Dexamethasone"
                },
                {
                    "id": "D000077212",
                    "term": "Ropivacaine"
                }
            ],
            "ancestors": [
                {
                    "id": "D000000893",
                    "term": "Anti-Inflammatory Agents"
                },
                {
                    "id": "D000000932",
                    "term": "Antiemetics"
                },
                {
                    "id": "D000001337",
                    "term": "Autonomic Agents"
                },
                {
                    "id": "D000018373",
                    "term": "Peripheral Nervous System Agents"
                },
                {
                    "id": "D000045505",
                    "term": "Physiological Effects of Drugs"
                },
                {
                    "id": "D000005765",
                    "term": "Gastrointestinal Agents"
                },
                {
                    "id": "D000005938",
                    "term": "Glucocorticoids"
                },
                {
                    "id": "D000006728",
                    "term": "Hormones"
                },
                {
                    "id": "D000006730",
                    "term": "Hormones, Hormone Substitutes, and Hormone Antagonists"
                },
                {
                    "id": "D000018931",
                    "term": "Antineoplastic Agents, Hormonal"
                },
                {
                    "id": "D000000970",
                    "term": "Antineoplastic Agents"
                },
                {
                    "id": "D000000779",
                    "term": "Anesthetics, Local"
                },
                {
                    "id": "D000000777",
                    "term": "Anesthetics"
                },
                {
                    "id": "D000002492",
                    "term": "Central Nervous System Depressants"
                },
                {
                    "id": "D000018689",
                    "term": "Sensory System Agents"
                }
            ],
            "browseLeaves": [
                {
                    "id": "M7102",
                    "name": "Dexamethasone",
                    "asFound": "High",
                    "relevance": "HIGH"
                },
                {
                    "id": "M235549",
                    "name": "Dexamethasone acetate",
                    "relevance": "LOW"
                },
                {
                    "id": "M4033",
                    "name": "Analgesics, Opioid",
                    "relevance": "LOW"
                },
                {
                    "id": "M1700",
                    "name": "Ropivacaine",
                    "asFound": "3 weeks",
                    "relevance": "HIGH"
                },
                {
                    "id": "M4217",
                    "name": "Anti-Inflammatory Agents",
                    "relevance": "LOW"
                },
                {
                    "id": "M4251",
                    "name": "Antiemetics",
                    "relevance": "LOW"
                },
                {
                    "id": "M8881",
                    "name": "Gastrointestinal Agents",
                    "relevance": "LOW"
                },
                {
                    "id": "M9047",
                    "name": "Glucocorticoids",
                    "relevance": "LOW"
                },
                {
                    "id": "M9789",
                    "name": "Hormones",
                    "relevance": "LOW"
                },
                {
                    "id": "M9788",
                    "name": "Hormone Antagonists",
                    "relevance": "LOW"
                },
                {
                    "id": "M20966",
                    "name": "Antineoplastic Agents, Hormonal",
                    "relevance": "LOW"
                },
                {
                    "id": "M4107",
                    "name": "Anesthetics",
                    "relevance": "LOW"
                },
                {
                    "id": "M4109",
                    "name": "Anesthetics, Local",
                    "relevance": "LOW"
                }
            ],
            "browseBranches": [
                {
                    "abbrev": "Infl",
                    "name": "Anti-Inflammatory Agents"
                },
                {
                    "abbrev": "ANeo",
                    "name": "Antineoplastic Agents"
                },
                {
                    "abbrev": "AnEm",
                    "name": "Antiemetics"
                },
                {
                    "abbrev": "Gast",
                    "name": "Gastrointestinal Agents"
                },
                {
                    "abbrev": "All",
                    "name": "All Drugs and Chemicals"
                },
                {
                    "abbrev": "Analg",
                    "name": "Analgesics"
                },
                {
                    "abbrev": "CNSDep",
                    "name": "Central Nervous System Depressants"
                }
            ]
        }
    },
    "hasResults": false
}